We suspect that Toll-like receptor 2 and Toll-like receptor 4 signaling pathways may promote Parkinson’s disease pathogenesis by increasing gut permeability and gut inflammation, thereby driving α-synuclein aggregation in the gut or brain. Here, TLR2 is linked to Parkinson disease.